You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Energy Efficient Oxygen Concentrator

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: NHLBI

    DESCRIPTION (provided by applicant): Project Summary/Abstract This project will improve the energy efficiency of home oxygen concentrators for patients on long-term oxygen therapy (LTOT) and save energy costs for the patients. The number of patients on LTOT is estimated to be 1.2 million. The cost of electricity can vary from one region, to another so it is difficult to determine the exact monthly ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Multimicrophone Adaptive Array Augmented with Visual Cueing

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: NIDCD

    DESCRIPTION (provided by applicant): Advanced Medical Electronics Corporation (AME) proposes to develop a smartphone-based adaptive audiovisual array that enables hearing aid users to converse with multiple speakers in reverberant environments with significant speech babble noise where their hearing aids do not function well. The array will consist of a smartphone, a smartphone accessory, and a sm ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  3. Face Recognition Tool for the Blind

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: NEI

    DESCRIPTION (provided by applicant): It is difficult for people who are blind or have low vision to recognize people in a variety of social interactions. Sole reliance on voice recognition may be difficult in some circumstances, and impossible in other circumstances, e.g., people within a group who do not speak. The inability to identify people during group meetings is a disadvantage for blind peo ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Nucleic acid delivery of growth factors and heparan sulfate proteoglycans for enh

    SBC: International Medicine and Biomedical Research            Topic: NIAMS

    DESCRIPTION (provided by applicant): In chronic wounds, numerous factors contribute to the diminished healing. Wound healing constituents, including heparan sulfate proteoglycans and numerous growth factors, are essential to normal skin wound healing. Several key growth factors such as FGF, VEGF, and PDGF require heparan sulfate-like polymers as co- receptors or co-activators for growth factor act ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  5. AMES+Brain Stimulation: Treatment for Profound Plegia in Stroke

    SBC: AMES TECHNOLOGY, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): An estimated 30% of chronic stroke patients with motor disabilities of the limbs are plegic in the hand or the foot - that is, they cannot move the hand or foot. While some plegic stroke patients have completely paralyzed muscles, without the ability to activate even minimally the plegic muscles ( profound plegia ), other plegic stroke patients are capable of p ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  6. High throughput screening of bacterial collections for surface proteins of commer

    SBC: APD LIFE SCIENCES, INC.            Topic: NCRR

    DESCRIPTION (provided by applicant): There is a recognized need for development of protein capture tools that will reliably detect a variety of targets, over a broad range of concentrations, for use with human plasma and other complex sample mixtures for diagnostic and therapeutic applications. The products from our PEARL [Pathogen-Encoded Adaptable Receptor Library] technology will yield antibody ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Not Available

    SBC: BioSavita, Inc.            Topic: NCI

    ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody cand ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  8. Augmented Reality Simulation for Teaching Medical Students

    SBC: ARCHIE MD INC.            Topic: NCRR

    DESCRIPTION (provided by applicant): The majority of medical procedural skills are learned during medical school and residency training. However, the amount of time and access students have to learn these skills is declining. Medical students have improved clinical performance when they have direct interaction with patients, yet as medical school class sizes increase, students have less access to ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  9. INTERACTIVE INFORMED CONSENT FOR PEDI

    SBC: ARCHIE MD INC.            Topic: NHLBI

    Not Available

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  10. A Novel Expansion of Primary Leukemia Stem Cells

    SBC: Arteriocyte, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Arteriocyte's long-term objective is to develop a platform for ex vivo expansion of leukemic stem cell (LSC) based on cytokine-enriched medium and the company's proprietary nanofiber culture scaffold (NANEX). Cancer stem cell research is of significant importance because, this approach has the potential to create an effective therapy that overcomes challenges o ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government